Frank Scherrer's practice focuses on the area of pharmaceutical and health law. He regularly advises and represents pharmaceutical companies in matters concerning marketing authorisation, establishment licences, health insurance reimbursement, advertising, distribution, the drafting of agreements of all types, data protection and product liability. He represents his clients in contract negotiations as well as in administrative and court proceedings. He also advises clients in the field of medical devices, cosmetics and functional food. Other areas of Frank Scherrer's expertise include cartel and unfair competition law, employment law and general corporate and contract law.

Frank Scherrer joined Wenger & Vieli in 1999 where he became a partner in 2005. He obtained his doctorate from the University of Zurich in 1996 for a thesis on Swiss and European merger control procedure. From 1993 to 1996 he worked at the Europa Institut Zurich and as an assistant at the law faculty. He gained an LLM from Exeter University (UK) and studied law in Neuchâtel.

Frank Scherrer speaks German, English and French.

Publications by Frank Scherrer include PLC's annual Multi-Jurisdictional Guide to Life Sciences (2005–2019); and Law Business Research's Getting the Deal Through – Life Sciences (2010–2019) and The Product Regulation and Liability Review (2016–2019). Other publications include "Das europäische und das schweizerische Fusionskontrollverfahren" (thesis, Zurich, 1996); "Fusionskontrolle nach revidiertem Kartellgesetz - erste Fälle und offene Fragen", in AJP (November 1997); "Die schweizerische Fusionskontrolle - bisherige Anläufe und Ansatz zum Sprung", in Schriftenreihe des Europa Instituts Zürich (vol 11); and "Aktuelle Fragen zum Wirtschaftsrecht - Zur Emeritierung von Walter R Schluep" (Zurich, 1996).

Frank Scherrer's practice focuses on the area of pharmaceutical and health law. He regularly advises and represents pharmaceutical companies in matters concerning marketing authorisation, establishment licences, health insurance reimbursement, advertising, distribution, the drafting of agreements of all types, data protection and product liability. He represents his clients in contract negotiations as well as in administrative and court proceedings. He also advises clients in the field of medical devices, cosmetics and functional food. Other areas of Frank Scherrer's expertise include cartel and unfair competition law, employment law and general corporate and contract law.

Frank Scherrer joined Wenger & Vieli in 1999 where he became a partner in 2005. He obtained his doctorate from the University of Zurich in 1996 for a thesis on Swiss and European merger control procedure. From 1993 to 1996 he worked at the Europa Institut Zurich and as an assistant at the law faculty. He gained an LLM from Exeter University (UK) and studied law in Neuchâtel.

Frank Scherrer speaks German, English and French.

Publications by Frank Scherrer include PLC's annual Multi-Jurisdictional Guide to Life Sciences (2005–2019); and Law Business Research's Getting the Deal Through – Life Sciences (2010–2019) and The Product Regulation and Liability Review (2016–2019). Other publications include "Das europäische und das schweizerische Fusionskontrollverfahren" (thesis, Zurich, 1996); "Fusionskontrolle nach revidiertem Kartellgesetz - erste Fälle und offene Fragen", in AJP (November 1997); "Die schweizerische Fusionskontrolle - bisherige Anläufe und Ansatz zum Sprung", in Schriftenreihe des Europa Instituts Zürich (vol 11); and "Aktuelle Fragen zum Wirtschaftsrecht - Zur Emeritierung von Walter R Schluep" (Zurich, 1996).